ARCHIVES

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Letter Protests Closed Meeting; NIH Calls Action Appropriate

August 12, 1994

NCI To Recompete NSABP in 1995, Chabner tells Senate

May 20, 1994

Lynch Named Director, Yale Cancer Center

February 27, 2009

Burzynski, Monaco Clashed In Court

June 5, 1992

New Cancer Education Program “Striking Change,” To Fund CR, Prebaccalaureate, Summer Training

June 20, 1986

NCAB Approves, NCI Accepts Powers’ Version Of Board’s Organ Systems Recommendations

May 27, 1983